Related content

Angiotensin II Regulates microRNA-132/-212 in Hypertensive Rats and Humans

By Eskildsen Tilde V.   Jeppesen Pia L.   Schneider Mikael   Nossent Anne Y.   Sandberg Maria B.   Hansen Pernille B. L.   Jensen Charlotte H.   Hansen Maria L.   Marcussen Niels   Rasmussen Lars M.   Bie Peter   Andersen Ditte C.   Sheikh Søren P.  

International Journal of Molecular Sciences, Vol. 14, Iss. 6, 2013-05 ,pp. : 11190-11207

MDPI

Access to resources Recommend Favorite

Angiotensin-(1-7) inhibits the angiotensin II-enhanced norepinephrine release in coarcted hypertensive rats

By Gironacci M.M.   Yujnovsky I.   Gorzalczany S.   Taira C.   Pena C.  

Regulatory Peptides, Vol. 118, Iss. 1, 2004-04 ,pp. : 45-49

Elsevier

Access to resources Recommend Favorite

QUANTITATIVE DETERMINATION OF FOUR ANGIOTENSIN-II-RECEPTOR ANTAGONISTS IN PRESENCE OF HYDROCHLOROTHIAZIDE BY A GRADIENT TECHNIQUE HPLC IN THEIR PHARMACEUTICAL PREPARATIONS

By Elshanawane Abdullah A.   Abdelaziz Lobna M.   Kamal Magda M.   Hafez Hani M.  

Journal of Liquid Chromatography & Related Technologies, Vol. 37, Iss. 2, 2014-01 ,pp. : 171-186

Taylor & Francis Ltd

Access to resources Recommend Favorite

Synthesis of New 1,2,4‐ and 1,3,4‐Oxadiazole Derivatives as Potential Nonpeptide Angiotensin II Receptor Antagonists

By Meyer Emerson   Joussef Antonio   de Souza Luciana  

Synthetic Communications, Vol. 36, Iss. 6, 2006-04 ,pp. : 729-741

Taylor & Francis Ltd

Access to resources Recommend Favorite

Therapeutic Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist, on CCl₄-Induced Skeletal Muscle Injury

By Hwang Ok-Kyung   Park Jin-Kyu   Lee Eun-Joo   Lee Eun-Mi   Kim Ah-Young   Jeong Kyu-Shik  

International Journal of Molecular Sciences, Vol. 17, Iss. 2, 2016-02 ,pp. : 227-227

MDPI

Access to resources Recommend Favorite